Wenchao Li

Nanjing, 210009, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications

ZNF263-NuRD-mediated repression of STAT1 curtails MHC-I antigen presentation and IFN-γ efficacy in prostate cancer.

ZNF263-NuRD-mediated repression of STAT1 curtails MHC-I antigen presentation and IFN-γ efficacy in prostate cancer.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 21, 2026

Identification of interleukin-11 as a comorbid risk factor for prostate cancer and Alzheimer's disease using integrated bioinformatics and machine learning.

Identification of interleukin-11 as a comorbid risk factor for prostate cancer and Alzheimer's disease using integrated bioinformatics and machine learning.

Journal: Frontiers in immunology
Published: June 17, 2026

HOXD11-NMDAR signaling drives neuroendocrine prostate cancer and enables potential therapeutic intervention as a target of memantine.

HOXD11-NMDAR signaling drives neuroendocrine prostate cancer and enables potential therapeutic intervention as a target of memantine.

Journal: Cell reports
Published: December 16, 2025

A conserved eIF1A+ luminal cell-centered hypoxic and "cold" tumor microenvironment promotes pan-subtype prostate cancer progression.

A conserved eIF1A+ luminal cell-centered hypoxic and "cold" tumor microenvironment promotes pan-subtype prostate cancer progression.

Journal: Cell reports. Medicine
Published: August 26, 2025

GNL3 Orchestrates AR Transcriptional Programs to Drive Castration-Resistant Prostate Cancer and Immune Evasion.

GNL3 Orchestrates AR Transcriptional Programs to Drive Castration-Resistant Prostate Cancer and Immune Evasion.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 26, 2025

Author Correction: Single-cell and spatial RNA sequencing identify divergent microenvironments and progression signatures in early- versus late-onset prostate cancer.

Author Correction: Single-cell and spatial RNA sequencing identify divergent microenvironments and progression signatures in early- versus late-onset prostate cancer.

Journal: Nature aging
Published: May 12, 2025

Systemic treatment of metastatic castration-sensitive prostate cancer: A meta-analysis of efficacy and safety.

Systemic treatment of metastatic castration-sensitive prostate cancer: A meta-analysis of efficacy and safety.

Journal: Medicine
Published: October 08, 2024

Matrix Metalloproteinase-9 is associated with tumor microenvironment remodeling of bladder cancer.

Matrix Metalloproteinase-9 is associated with tumor microenvironment remodeling of bladder cancer.

Journal: Biology direct
Published: September 24, 2024

YY1 enhances HIF-1α stability in tumor-associated macrophages to suppress anti-tumor immunity of prostate cancer in mice.

YY1 enhances HIF-1α stability in tumor-associated macrophages to suppress anti-tumor immunity of prostate cancer in mice.

Journal: Nature communications
Published: July 24, 2024

Inhibition of PRMT5 moderately suppresses prostate cancer growth in vivo but enhances its response to immunotherapy.

Inhibition of PRMT5 moderately suppresses prostate cancer growth in vivo but enhances its response to immunotherapy.

Journal: Cancer letters
Published: May 07, 2024

Identification of an anaplastic subtype of prostate cancer amenable to therapies targeting SP1 or translation elongation.

Identification of an anaplastic subtype of prostate cancer amenable to therapies targeting SP1 or translation elongation.

Journal: Science advances
Published: April 03, 2024

Single-cell and spatial RNA sequencing identify divergent microenvironments and progression signatures in early- versus late-onset prostate cancer.

Single-cell and spatial RNA sequencing identify divergent microenvironments and progression signatures in early- versus late-onset prostate cancer.

Journal: Nature aging
Published: March 27, 2024
Showing 1-12 of 25

Last Updated: 09/26/2026